Stephen R. Brady

Insider Reports History

Entity
Individual
Location
C/O Immune Design Corp., 1616 Eastlake Ave. E, Suite 310, Seattle, WA
Signature
/s/ Nicholas Maestas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen R. Brady:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Tempest Therapeutics, Inc. President and CEO, Director Common Stock 46.4K $97.9K $2.11 Jul 3, 2024 Direct
Tempest Therapeutics, Inc. President and CEO, Director Employee Stock Option (right to buy) 250K Jan 3, 2024 Direct
Atreca, Inc. Director Stock Option (right to buy) 12K Jun 13, 2023 Direct

Insider Reports Filed by Stephen R. Brady

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TPST Tempest Therapeutics, Inc. Jul 3, 2024 1 $73.9K 4 Jul 8, 2024 President and CEO, Director
TPST Tempest Therapeutics, Inc. Jan 3, 2024 1 $0 4 Jan 5, 2024 President and CEO, Director
TPST Tempest Therapeutics, Inc. Oct 11, 2023 1 $0 4 Oct 13, 2023 President and CEO, Director
BCEL Atreca, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
TPST Tempest Therapeutics, Inc. Jan 3, 2023 1 $0 4 Jan 5, 2023 Chief Executive Officer, Director
TPST Tempest Therapeutics, Inc. Jun 21, 2022 1 $0 4 Jun 22, 2022 Chief Executive Officer, Director
BCEL Atreca, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
TPST Tempest Therapeutics, Inc. Jan 4, 2022 1 $0 4 Jan 6, 2022 Chief Executive Officer, Director
BCEL Atreca, Inc. Jul 14, 2021 1 $0 4 Jul 16, 2021 Director
BCEL Atreca, Inc. Jul 14, 2021 0 $0 3 Jul 16, 2021 Director
TPST Millendo Therapeutics, Inc. Jun 25, 2021 4 $0 4 Jun 29, 2021 Chief Executive Officer, Director
TPST Millendo Therapeutics, Inc. Jun 25, 2021 0 $0 3 Jun 29, 2021 Chief Executive Officer, Director